Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction.
D000208:Acute Disease; D000284:Administration, Oral; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005081:Exercise Therapy; D005340:Fibrinogen; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D007456:Iodine Isotopes; D007866:Leg / Q000098:blood supply*; D009068:Movement; D009203:Myocardial Infarction / Q000150:complications*; D011379:Prognosis; D013924:Thrombophlebitis / Q000175:diagnosis / Q000517:prevention & control*; D013997:Time Factors; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D000925:Anticoagulants; D007456:Iodine Isotopes; D014859:Warfarin; D005340:Fibrinogen; D006493:Heparin